Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies. | Front Genet | 2022 | 36226177 | PubTator, text mining | PubMed |
| SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression. | Cancer Inform | 2022 | 36225330 | PubTator, text mining | PubMed |
| Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study. | Front Endocrinol (Lausanne) | 2022 | 36225201 | PubTator, text mining | PubMed |
| Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2. | Life Sci | 2022 | 36209833 | PubTator, text mining | PubMed |
| MicroRNA-29a inhibits collagen expression and induces apoptosis in human fetal scleral fibroblasts by targeting the Hsp47/Smad3 signaling pathway. | Exp Eye Res | 2022 | 36206860 | PubTator, text mining | PubMed |
| Neuropilin-1 modulates the 3D invasive properties of glioblastoma stem-like cells. | Front Cell Dev Biol | 2022 | 36204684 | PubTator, text mining | PubMed |
| Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods. | Front Immunol | 2022 | 36203586 | PubTator, text mining | PubMed |
| Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage. | Nat Commun | 2022 | 36195613 | PubTator, text mining | PubMed |
| Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models. | Elife | 2022 | 36193675 | PubTator, text mining | PubMed |
| Conservation at the uterine-placental interface. | Proc Natl Acad Sci U S A | 2022 | 36191208 | PubTator, text mining | PubMed |
| Identification of the circRNA-miRNA-mRNA regulatory network in osteoarthritis using bioinformatics analysis. | Front Genet | 2022 | 36186471 | PubTator, text mining | PubMed |
| Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study. | Medicine (Baltimore) | 2022 | 36181098 | PubTator, text mining | PubMed |
| A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL). | Front Immunol | 2022 | 36177005 | PubTator, text mining | PubMed |
| New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors. | Front Pharmacol | 2022 | 36172198 | PubTator, text mining | PubMed |
| Lotus germ extract rejuvenates aging fibroblasts via restoration of disrupted proteostasis by the induction of autophagy. | Aging (Albany NY) | 2022 | 36170016 | PubTator, text mining | PubMed |
| Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming. | Cell Oncol (Dordr) | 2022 | 36169805 | PubTator, text mining | PubMed |
| Potential Biomarkers and Signaling Pathways Associated with the Pathogenesis of Primary Ameloblastoma: A Systems Biology Approach. | Int J Dent | 2022 | 36160115 | PubTator, text mining | PubMed |
| Closer to Nature: The Role of MSCs in Recreating the Microenvironment of the Hematopoietic Stem Cell Niche in vitro. | Transfus Med Hemother | 2022 | 36159960 | PubTator, text mining | PubMed |
| An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas. | Diagn Pathol | 2022 | 36153549 | PubTator, text mining | PubMed |
| Nondestructive protein sampling with electroporation facilitates profiling of spatial differential protein expression in breast tumors in vivo. | Sci Rep | 2022 | 36151122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=29